Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|September 2, 2017
Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark studyThomas Rose, Andreas Grützkau, Jens Klotsche, et al.
European Journal of Immunology|October 19, 2016
Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophagesJan Klocke, Katharina Kopetschke, Anna-Sophie Grießbach, et al.
Critical Care Medicine|January 18, 2024
Robotic-Assisted In-Bed Mobilization in Ventilated ICU Patients With COVID-19: An Interventional, Randomized, Controlled Pilot Study (ROBEM II Study)Marco Lorenz, Felix Baum, Philipp Kloss, et al.
International Journal of Molecular Sciences|July 2, 2021
Differences between Human and Mouse IgM Fc Receptor (FcµR)Hiromi Kubagawa, Christopher M Skopnik, Khlowd Al-Qaisi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cellsGabriela Riemekasten, Dirk Langnickel, Philipp Enghard, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|September 25, 2020
Establishment of an extracorporeal cardio-pulmonary resuscitation program in Berlin - outcomes of 254 patients with refractory circulatory arrestJens Nee, Roland Koerner, Daniel Zickler, et al.
Annals of the Rheumatic Diseases|November 3, 2012
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosusThomas Rose, Andreas Grützkau, Heike Hirseland, et al.
Trials|June 27, 2020
CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trialHelena Stockmann, Theresa Keller, Stefan Büttner, et al.
Annals of the Rheumatic Diseases|September 2, 2015
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusCaroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, et al.
Critical Care (London, England)|June 11, 2024
Standard vs. carbone dioxide adapted kidney replacement therapy in hypercapnic ARDS patients: a randomized controlled pilot trial (BigBIC)Julius Valentin Kunz, Helena Hansmann, Mareike Fähndrich, et al.
Pageof 8